Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Neurology

Building Your Multidisciplinary Care Team

At a Glance

Progressive muscular atrophy care is best coordinated through a multidisciplinary team, typically including a neuromuscular neurologist, nurse coordinator, respiratory and rehabilitation specialists, speech and nutrition professionals, and psychosocial or palliative support.

Because Progressive Muscular Atrophy (PMA) is a complex and rare condition, managing it requires more than just a single doctor. The gold standard for care is a multidisciplinary clinic—a specialized center where a team of experts works together to address every aspect of the disease in one location. Research shows that patients who receive care at these specialized centers are associated with better coordination and, in observational studies, often improved outcomes than those seen in general neurology clinics [1][2].

Why Specialized Centers Matter

In a general clinic, you might see a neurologist who only encounters a case of PMA once every few years. In contrast, ALS Recognized Treatment Centers or Certified Treatment Centers of Excellence (though these specific designations may not exist in all countries) are staffed by professionals who specialize exclusively in motor neuron diseases [3][4].

These centers provide “one-stop” care, meaning you can see several specialists during a single afternoon. This coordination ensures that your physical therapist knows exactly what your pulmonologist found during your breathing test, allowing them to adjust your care plan in real-time. If access is an issue due to geography, an MND or neuromuscular clinic can be an appropriate alternative, especially by utilizing telehealth [5][6].

The Essential Members of Your Team

A comprehensive PMA care team should include the following specialists, each focusing on a different “domain” of your health [5][7]:

  • Neuromuscular Neurologist: The team leader. They should have specific expertise in interpreting EMG/NCS results to distinguish PMA from “mimics” like Multifocal Motor Neuropathy (MMN) [4][8].
  • MND Nurse Coordinator: Your primary point of contact. They help coordinate appointments, manage prescriptions, and ensure communication between you and the rest of the team [6].
  • Pulmonologist or Respiratory Therapist: They monitor your breathing strength and manage Non-Invasive Ventilation (NIV) and cough-assist devices [9][10].
  • Physical (PT) and Occupational (OT) Therapists: They focus on mobility, safety, and independence. They can help you get fitted for the right wheelchair or recommend home modifications [7].
  • Speech-Language Pathologist (SLP): Essential for managing changes in speech and swallowing safety [11].
  • Registered Dietitian: Focuses on weight maintenance and nutritional health, which are linked to slower disease progression [12][13].
  • Social Worker or Psychologist: Provides emotional support and helps navigate the complex financial and practical aspects of living with a chronic illness [14][15].

Vetting Your Neurologist’s Experience

When you first meet your neurologist, it is important to understand their level of experience with Lower Motor Neuron (LMN) diseases. You may want to ask how they stay current with the latest diagnostic frameworks, such as the Gold Coast criteria [16].

A specialist who understands the “PMA spectrum” will not just look at your muscles; they will also perform routine screenings for cognitive changes and discuss advance-care planning early on [17][18]. This proactive approach ensures that you remain in control of your care decisions at every stage of the journey [19][20].

Palliative Care: More Than End-of-Life

Many specialized clinics now include palliative care early in the diagnosis. Palliative care is not the same as hospice; it is a specialty focused on relieving symptoms and improving quality of life at any stage of a serious illness [20][21]. Early involvement of a palliative specialist can help with complex symptom management—like pain or saliva control—and support you in making important decisions about your future care [6][22].

Common questions in this guide

What does a multidisciplinary care team do for PMA?
A multidisciplinary PMA team brings several specialists together so care is coordinated rather than managed through disconnected appointments. It may include a neuromuscular neurologist, nurse coordinator, respiratory specialist, physical and occupational therapists, speech-language pathologist, dietitian, and social worker or psychologist.
How can I tell whether a neurologist has experience with progressive muscular atrophy?
Ask how often the neurologist treats lower motor neuron or motor neuron diseases and how they use electrical nerve and muscle tests to evaluate PMA and possible mimics. You can also ask whether they follow current diagnostic criteria, screen for cognitive changes, and discuss advance-care planning.
What does a respiratory specialist do in PMA care?
A pulmonologist or respiratory therapist monitors breathing strength and related test results. They can help manage non-invasive ventilation and cough-assist devices and share findings with the rest of the care team.
Is palliative care the same as hospice for progressive muscular atrophy?
No. Palliative care can be added at any stage of PMA to relieve symptoms, support quality of life, and help with difficult care decisions; it is not limited to end-of-life care. It may help address problems such as pain or saliva control.
Can telehealth help if I live far from a PMA specialty clinic?
Yes, telehealth may help connect you with a motor neuron disease or neuromuscular clinic while local clinicians provide hands-on care. Ask whether specialists can coordinate with your local providers, since available services and telehealth rules vary by location.
How can a PMA care team support caregivers?
A social worker or psychologist can provide emotional support and help with practical, financial, and caregiving concerns. They may also help caregivers find respite care or other support systems.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Progressive muscular atrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does your multidisciplinary team include a dedicated respiratory therapist and a speech-language pathologist who specialize in motor neuron diseases?
  2. 2.How often will we meet as a full team versus having individual specialist appointments?
  3. 3.Can we discuss practical symptom management for things like cramps, fatigue, and emotional well-being?
  4. 4.At what point in my disease progression do you typically introduce palliative care to help with complex symptom management?
  5. 5.If I live far away, are there telehealth options or ways to coordinate care with my local providers?

References

References (22)
  1. 1

    Oropharyngeal Dysphagia as the Main Expression of Amyotrophic Lateral Sclerosis.

    Rugaitienė M, Damulevičienė G, Lesauskaitė V, Ulozienė I

    Medicina (Kaunas, Lithuania) 2022; (58(5)) doi:10.3390/medicina58050647.

    PMID: 35630064
  2. 2

    Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis.

    de Almeida FEO, do Carmo Santana AK, de Carvalho FO

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(3)):911-923 doi:10.1007/s10072-020-05011-2.

    PMID: 33443670
  3. 3

    Early diagnosis of amyotrophic lateral sclerosis mimic syndromes: pros and cons of current clinical diagnostic criteria.

    Cortés-Vicente E, Pradas J, Marín-Lahoz J, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2017; (18(5-6)):333-340 doi:10.1080/21678421.2017.1316408.

    PMID: 28440098
  4. 4

    Electrodiagnostic Assessment of Motor Neuron Disease.

    Kang X, Quan D

    Neurologic clinics 2021; (39(4)):1071-1081 doi:10.1016/j.ncl.2021.06.008.

    PMID: 34602215
  5. 5

    Amyotrophic lateral sclerosis: update on clinical management.

    Norris SP, Likanje MN, Andrews JA

    Current opinion in neurology 2020; (33(5)):641-648 doi:10.1097/WCO.0000000000000864.

    PMID: 32868602
  6. 6

    End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease.

    Cheng HWB, Chan OMI, Chan CHR, et al.

    The American journal of hospice & palliative care 2018; (35(6)):847-851 doi:10.1177/1049909117735832.

    PMID: 29034688
  7. 7

    Exploring Advancements in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review of Current Modalities and Future Prospects.

    Hoxhaj P, Hastings N, Kachhadia MP, et al.

    Cureus 2023; (15(9)):e45489 doi:10.7759/cureus.45489.

    PMID: 37868386
  8. 8

    Differentiating lower motor neuron syndromes.

    Garg N, Park SB, Vucic S, et al.

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(6)):474-483 doi:10.1136/jnnp-2016-313526.

    PMID: 28003344
  9. 9

    The Benefit of Non-invasive Ventilation in Motor Neuron Disease.

    Walsh LJ, Murphy DM

    The open respiratory medicine journal 2020; (14()):53-61 doi:10.2174/1874306402014010053.

    PMID: 33425067
  10. 10

    Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.

    Berlowitz DJ, Howard ME, Fiore JF, et al.

    Journal of neurology, neurosurgery, and psychiatry 2016; (87(3)):280-6 doi:10.1136/jnnp-2014-310055.

    PMID: 25857659
  11. 11

    Accessing and Receiving Speech-Language Pathology Services at the Multidisciplinary Amyotrophic Lateral Sclerosis Clinic: An Exploratory Qualitative Study of Patient Experiences and Needs.

    Huynh A, Adams K, Barnett-Tapia C, et al.

    Journal of speech, language, and hearing research : JSLHR 2024; (67(10S)):4025-4037 doi:10.1044/2023_JSLHR-23-00087.

    PMID: 37678221
  12. 12

    Supportive & palliative interventions in motor neurone disease: what we know from current literature?

    Cheng HWB, Chan KY, Chung YKJ, et al.

    Annals of palliative medicine 2018; (7(3)):320-331 doi:10.21037/apm.2017.10.01.

    PMID: 29156920
  13. 13

    Evaluation of Dysphagia in Motor Neuron Disease. Review of Available Diagnostic Tools and New Perspectives.

    Romero-Gangonells E, Virgili-Casas MN, Dominguez-Rubio R, et al.

    Dysphagia 2021; (36(4)):558-573 doi:10.1007/s00455-020-10170-7.

    PMID: 32797289
  14. 14

    Supportive care needs of patients with amyotrophic lateral sclerosis/motor neuron disease and their caregivers: A scoping review.

    Oh J, Kim JA

    Journal of clinical nursing 2017; (26(23-24)):4129-4152 doi:10.1111/jocn.13945.

    PMID: 28681543
  15. 15

    Psychological distress in partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: what's the role of care demands and perceived control?

    de Wit J, Beelen A, van den Heerik MS, et al.

    Psychology, health & medicine 2020; (25(3)):319-330 doi:10.1080/13548506.2019.1686646.

    PMID: 31747791
  16. 16

    [Motor neuron diseases from a radiological perspective : Focus on amyotrophic lateral sclerosis].

    Warmann S

    Radiologie (Heidelberg, Germany) 2026; (66(4)):272-277 doi:10.1007/s00117-026-01577-8.

    PMID: 41714394
  17. 17

    Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes.

    de Vries BS, Rustemeijer LMM, Bakker LA, et al.

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(2)):141-147 doi:10.1136/jnnp-2018-318788.

    PMID: 30076267
  18. 18

    Advance care planning in motor neuron disease: A systematic review.

    Murray L, Butow PN

    Palliative & supportive care 2016; (14(4)):411-32 doi:10.1017/S1478951515001066.

    PMID: 26462880
  19. 19

    Advance care planning in motor neuron disease: A qualitative study of caregiver perspectives.

    Murray L, Butow PN, White K, et al.

    Palliative medicine 2016; (30(5)):471-8 doi:10.1177/0269216315613902.

    PMID: 26847526
  20. 20

    Requested withdrawal of gastrostomy feeding in motor neurone disease.

    Wakefield D, Hanson SR

    BMJ supportive & palliative care 2023; (13(e1)):e88-e90 doi:10.1136/bmjspcare-2020-002428.

    PMID: 32709706
  21. 21

    A 10-year service evaluation of a multidisciplinary neuro-palliative care model in motor neuron disease: Impact on palliative care service delivery & advance care planning.

    Chung WKV, Chan KP, Hsu DY, et al.

    Palliative medicine 2025; 2692163251396020 doi:10.1177/02692163251396020.

    PMID: 41399314
  22. 22

    Caregivers' View of Socio-Medical Care in the Terminal Phase of Amyotrophic Lateral Sclerosis-How Can We Improve Holistic Care in ALS?

    Linse K, Aust E, Günther R, Hermann A

    Journal of clinical medicine 2022; (11(1)) doi:10.3390/jcm11010254.

    PMID: 35011995

This page is for informational purposes only and does not constitute medical advice. Discuss your care team, symptoms, and treatment decisions with your neurologist and other qualified clinicians.